Intuitive Surgical, Inc. $ISRG Shares Newly Acquired by Inspire Trust Co. N.A.

Inspire Trust Co. N.A. bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 14,000 shares of the medical equipment provider’s stock, valued at approximately $5,693,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Main Street Group LTD acquired a new position in shares of Intuitive Surgical during the 1st quarter worth about $30,000. North Point Portfolio Managers Corp OH bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $27,000. John Boyer Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $27,000. Compass Wealth Management LLC acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $29,000. Finally, Evergreen Advisors LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter valued at approximately $35,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 2.3%

NASDAQ:ISRG opened at $450.04 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The business has a 50 day moving average price of $413.15 and a two-hundred day moving average price of $431.20. The company has a market cap of $156.00 billion, a P/E ratio of 54.42, a price-to-earnings-growth ratio of 3.17 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same period last year, the company earned $2.40 earnings per share. The firm’s revenue was up 21.7% compared to the same quarter last year. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. Stifel Nicolaus lowered their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research note on Friday, July 17th. Barclays reiterated an “overweight” rating and issued a $500.00 target price (up from $485.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $493.54.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Gary Guthart sold 20,095 shares of the firm’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the transaction, the director owned 1,204,530 shares of the company’s stock, valued at approximately $543,977,793.30. This trade represents a 1.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia Wadors sold 1,078 shares of the firm’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total transaction of $478,416.40. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 39,056 shares of company stock valued at $17,585,864 in the last three months. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.